Corbus Pharmaceuticals Holdings, Inc. Grants Receivable, Current
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Grants Receivable, Current of $500.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes
us-gaap:GrantsReceivableCurrent · last filed 2018-03-12
- 2017-09-30: Grants Receivable, Current $500.00K.
- 2016-12-31: Grants Receivable, Current $1.00M.
| Period end | Grants Receivable, Current |
|---|---|
| 2017-09-30 | $500.00K 10-Q · filed 2017-11-08 |
| 2016-12-31 | $1.00M 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |